NCT06432491 The Association Between Core Temperature and Health
| NCT ID | NCT06432491 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences |
| Condition | Body Temperature Changes |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2025-01-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if cold water drinking could promote body composition and further extend healthy lifespan in Chinese older adults. The main questions it aims to answer are: 1. Does cold water drinking lower the body fat percentage? 2. Will cold water drinking positively extend lifespan in a long-term Researchers will compare cold water intervention group to a control group (drinking 37℃ water instead) to see if cold water drinking works to promote health and slow down ageing process. Participants will: 1. Drink 4℃ or 37℃ water 4 times (9a.m., 12p.m., 15p.m., 18p.m.) every day for 6 months. 2. Visit the institute and health checkup department for tests and checkup at baseline, the end of the 3rd month, and the end of 6th month.
Eligibility Criteria
Inclusion Criteria: * Aged between 50 and 65 years old (including 50 and 65) * No surgery in the past 6 months * Healthy (No metabolic diseases, cardiovascular diseases, lung diseases (COPD, asthma, et al.), endocrine diseases and gastrointestinal diseases) * Based in Shenzhen during the whole study period * No significant change on body weight in the past 3 months Exclusion Criteria: * Those who need to take medication for a long term (including diet pills) * On a diet * Disabled * Females who are trying to get pregnant, pregnant, or breastfeeding * Presence of a metal implant in the body (e.g. pacemaker) * Those with claustrophobia * Those with blood phobia, pathological hypotension or hypertension * Those who are in other intervention studies
Contact & Investigator
John R Speakman, PhD
STUDY CHAIR
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Frequently Asked Questions
Who can join the NCT06432491 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 65 Years, studying Body Temperature Changes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06432491 currently recruiting?
Yes, NCT06432491 is actively recruiting participants. Contact the research team at j.speakman@abdn.ac.uk for enrollment information.
Where is the NCT06432491 trial being conducted?
This trial is being conducted at Shenzhen, China.
Who is sponsoring the NCT06432491 clinical trial?
NCT06432491 is sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The principal investigator is John R Speakman, PhD at Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The trial plans to enroll 36 participants.